Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to investigate the efficacy of retapamulin to reduce carriage of MRSA via a randomized, double-blind, placebo-controlled clinical study testing retapamulin among patients with confirmed mupirocin-resistant nasal and/or rectal MRSA colonization. The sample size will include 27 subjects in each of the two arms of the study (retapamulin versus placebo) for a total of 54 subjects. Participants who are found to be nasal and/or rectal colonized with MRSA will be randomized to receive either retapamulin or placebo applied nasally and rectally for a total of 5 days. Nasal and rectal swabs will be collected at pre-defined time points during study duration (screening swab, swab one week after completion of topical therapy, swab 4 weeks after completion of topical therapy) to assess MRSA colonization status. The colonization rates of both groups will be assessed via Fisher's Exact Test.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03304873
Study type Interventional
Source NYU Langone Health
Contact
Status Completed
Phase Phase 3
Start date December 1, 2017
Completion date March 18, 2019

See also
  Status Clinical Trial Phase
Completed NCT03181932 - AeroVanc in the Treatment of Methicillin-resistant Staphylococcus Aureus Infection in Patients With Cystic Fibrosis Phase 3
Completed NCT03268122 - Comparison of Standard Isolation With Targeted Isolation for Preventing Nosocomial Transmission of MRSA and VRE N/A
Completed NCT04312776 - Tracing MRSA in Households With Patients Infected With CA-MRSA by WGS
Recruiting NCT04104178 - Optimal Treatment of MRSA Throat Carriers Phase 3
Recruiting NCT04793152 - Vancomycin Dosing for Serious MRSA Infections: A Non-inferiority Randomized Trial of Trough Level Versus AUC/MIC N/A
Completed NCT03601741 - Use of Disposable Stethoscope Covers for Reduction of Stethoscope MRSA Contamination N/A
Completed NCT02690415 - Community-Assoc. S. Aureus Colonization and Recurrent Infection in Pts With Uncomplicated S. Aureus Skin Abscesses
Enrolling by invitation NCT04297592 - Antibiotic Prophylaxis in High-Risk Arthroplasty Patients Phase 4
Recruiting NCT05268120 - MRSA Decolonization in Complicated Carriage N/A
Completed NCT01167452 - Effect of Weight and/or Obesity on Sulfamethoxazole and Trimethoprim Concentrations Phase 4
Recruiting NCT04083092 - Surveillance of Community-Associated MRSA
Recruiting NCT02443064 - Pharmacokinetics/ Pharmacodynamics (PK/PD) Study of Vancomycin Phase 4
Completed NCT02029872 - Stop Community MRSA Colonization Among Patients Phase 4
Not yet recruiting NCT05696132 - Evaluation of the Decolonization Rate and Acceptance of a Complete Nasal Decolonization Kit With Povidone Iodine for MRSA Patients Phase 2
Recruiting NCT02127658 - MRSA Eradication and Decolonization in Children N/A
Completed NCT00822276 - The Underlying Mechanisms For S. Aureus Infection And Colonization Of Skin in People With Atopic Dermatitis With And Without Eczema Herpeticum (MRSA) N/A
Withdrawn NCT02547116 - Epidemiology and Treatment of Small-colony Variant Staphylococcus Aureus in Cystic Fibrosis Phase 4
Completed NCT01318213 - Benefits of Universal Glove and Gowning
Enrolling by invitation NCT05395520 - Vancomycin Monitoring: Is AUC Monitoring Appropriate for More Than Just Serious MRSA Infections?